Exane Derivatives’s Pebblebrook Hotel Trust PEB Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2018
Q1
Sell
-11,544
Closed -$429K 651
2017
Q4
$429K Buy
+11,544
New +$427K 0.07% 185
2017
Q3
Sell
-1
Closed -$32 629
2017
Q2
$32 Buy
+1
New +$31 ﹤0.01% 605
2017
Q1
Sell
-1
Closed -$30 638
2016
Q4
$30 Hold
1
﹤0.01% 596
2016
Q3
$27 Sell
1
-14,446
-100% -$415K ﹤0.01% 588
2016
Q2
$379K Buy
+14,447
New +$383K 0.06% 156

Other funds holding PEB

Exane Derivatives's PEB Position: Q1 2018 in Review

Exane Derivatives sold out of Pebblebrook Hotel Trust (PEB) in Q1 2018, closing a stake of 11,544 shares — an estimated $429K sold.

Exane Derivatives first reported a position in PEB in Q2 2016 and held it in 5 quarters. The position peaked at $429K in Q4 2017. 218 funds tracked by Wall St. Rank hold PEB as of Q1 2018.

  • Exane Derivatives reported no remaining Pebblebrook Hotel Trust position as of Q1 2018 after selling out during the quarter.
  • Exane Derivatives sold 11,544 Pebblebrook Hotel Trust shares in Q1 2018, an estimated $429K.
  • Exane Derivatives first reported a position in Pebblebrook Hotel Trust in Q2 2016 and held it in 5 quarters.
  • Exane Derivatives's Pebblebrook Hotel Trust position peaked at $429K in Q4 2017.
  • 218 funds tracked by Wall St. Rank held Pebblebrook Hotel Trust as of Q1 2018.

Based on Exane Derivatives's 13F filing for Q1 2018, filed 30 Apr 2018.